PARP2 and ovarian carcinoma: Genetically engineered fibroblasts.423 SNU‐251 (human ovarian carcinoma cell line), SKOV3 cells.424 MDA‐MB‐231 xenografts.423, 425 Probe does not bind to PARP‐2, shows specific binding in lymph nodes and spine.426